Neurodegeneration in multiple sclerosis: The role of oxidative stress and excitotoxicity von Gonsette, R.E

Volltext

Oxidative stress and excitotoxicity : a therapeutic issue in multiple sclerosis? von GONSETTE, R. E

Volltext

Self-tolerance in multiple sclerosis von Gonsette, R. E.

Volltext

Cardiac adverse effects associated with mitoxantrone (Novantrone) therapy in patients with MS von GHALIE, R. G, EDAN, G, LAURENT, M, MAUCH, E, EISENMAN, S, HARTUNG, H. P, GONSETTE, R. E, BUTINE, M. D, GOODKIN, D. E

Volltext

Mitoxantrone in progressive multiple sclerosis: when and how to treat? von Gonsette, R.E

Volltext

New immunosuppressants with potential implication in multiple sclerosis von Gonsette, R.E.

Volltext

Pixantrone (BBR2778): a new immunosuppressant in multiple sclerosis with a low cardiotoxicity von Gonsette, R.E

Volltext

A study of therapy-related acute leukaemia after mitoxantrone therapy for multiple sclerosis von Ghalie, R G, Mauch, E, Edan, G, Hartung, H P, Gonsette, R E, Eisenmann, S, Le Page, E, Butine, M D, Goodkin, D E

Volltext

Endogenous neuroprotection in multiple sclerosis von GONSETTE, R. E

Volltext

Mitoxantrone immunotherapy in multiple sclerosis von Gonsette, RE

Volltext

Mitoxantrone in progressive multiple sclerosis: a placebo-controlled, double-blind, randomised, multicentre trial von Hartung, Hans-Peter, Gonsette, Richard, Konig, Nikolaus, Kwiecinski, Hubert, Guseo, Andreas, Morrissey, Sean P, Krapf, Hilmar, Zwingers, Thomas

Volltext

Boosting endogenous neuroprotection in multiple sclerosis: the ASsociation of Inosine and Interferon β in relapsing- remitting Multiple Sclerosis (ASIIMS) trial von Gonsette, Richard E, Sindic, Christian, D'hooghe, Marie B, De Deyn, Peter-Paul, Medaer, Robert, Michotte, Alex, Seeldrayers, Pierrette, Guillaume, Daniel

Volltext

Effect of mitoxantrone on MRI in progressive MS: Results of the MIMS trial von Krapf, H., Morrissey, S. P., Zenker, O., Zwingers, T., Gonsette, R., Hartung, H. -P.

Volltext

Homolateral disappearance of essential tremor after cerebellar stroke von Dupuis, M. J. M., Delwaide, P. J., Boucquey, D., Gonsette, R. E.

Volltext

Introductory remarks: immunosuppressive and immunomodulating drugs, where and how do they act? von Gonsette, RE

Volltext

Effect of mitoxantrone on MRI in progressive MS: results of the MIMS trial von Krapf, H, Morrissey, S P, Zenker, O, Zwingers, T, Gonsette, R, Hartung, H-P

Volltext

Guidance on new therapies in multiple sclerosis patients von Gonsette, RE

Volltext

Guidance concerning compensation for new therapies in multiple sclerosis patients von Gonsette, R. E.

Volltext

Randomized controlled trial of interferon-beta-1a in secondary progressive MS : Clinical results von Secondary Progressive Efficacy Clinical Trial of Recombinant Interferon-Beta-1a in MS (SPECTRIMS) Study Group, Secondary Progressive Efficacy Clinical Trial of Recombinant Interferon-beta-1a in MS (SPECTRIMS) Study Group

Volltext

Review: Oxidative stress and excitotoxicity: a therapeutic issue in multiple sclerosis? von Gonsette, R.E.

Volltext